$VNRX
Volitionrx Ltd
NYSE · Healthcare · In Vitro & In Vivo Diagnostic Substances · Henderson, NV
VNRX chart
What traders are saying about $VNRX
Latest postsVolitionrx Ltd news
- VolitionRx, Missionpharma Explore Launch of Point-of-Care Sepsis Test
GenomeWeb ·
- VolitionRx Hooks up with Missionpharma
Baystreet.ca ·
- VolitionRx partners with Missionpharma to devel...
Pluang ·
- VolitionRx signs letter of intent with Missionpharma By Investing.com
Investing.com Nigeria ·
- VolitionRx signs non-binding LOI with Missionpharma on NETosis test
StreetInsider ·
- VolitionRx Signs LOI with Missionpharma to explore the Development and Launch of Volition's Lateral Flow Technology for NETosis Worldwide
Yahoo Finance ·
- An estimated 2.3 million newborns die yearly. VolitionRx and Missionpharma explore a finger-prick newborn sepsis test.
Stock Titan ·
- VolitionRx Limited (VNRX) Signs LOI to Develop NETosis Lateral Flow Test
TradingView ·
- VolitionRx prepays $500,000 on convertible note to Lind By Investing.com
Investing.com Nigeria ·
- VolitionRx makes $500,000 cash payment on convertible note
StreetInsider ·
- VolitionRx Limited Announces $500,000 Partial Pre-Payment of Convertible Note in Cash
Yahoo Finance ·
- VolitionRx Limited (VNRX) Prepays $500K, Secures Conversion Waiver
TradingView ·
Volitionrx Ltd key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $1.7M | $1.2M | $775,302 | $306,392 |
| Net income | -$23.4M | -$27.0M | -$35.7M | -$30.6M |
| Diluted EPS | – | $-0.31 | $-0.50 | – |
| Total assets (year end) | $6.9M | $9.4M | $28.0M | $18.3M |
| Cash and equivalents (year end) | $1.1M | $3.3M | $20.7M | $10.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Volitionrx Ltd
- Ticker
- VNRX (NYSE)
- Industry
- In Vitro & In Vivo Diagnostic Substances
- Headquarters
- Henderson, NV
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 93314
- Former names
- VOLITIONRX LTD, STANDARD CAPITAL CORP
Frequently asked questions
What exchange is Volitionrx Ltd listed on?
Volitionrx Ltd trades on the NYSE under the ticker symbol VNRX.
What industry is Volitionrx Ltd in?
Volitionrx Ltd is classified by the SEC under "In Vitro & In Vivo Diagnostic Substances", part of the Healthcare sector on StockTweeting.
Where is Volitionrx Ltd headquartered?
Volitionrx Ltd's business address on file with the SEC is in Henderson, NV.
When does Volitionrx Ltd's fiscal year end?
Volitionrx Ltd's fiscal year ends on December 31.
How much revenue did Volitionrx Ltd report?
Volitionrx Ltd reported $1.7M in revenue for calendar year 2025, according to its SEC filings.